CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale SVP, General Counsel&Secretary sold 3,971 shares at $0.72 ($2,866)
- 4 Open-market sale President and CEO sold 3,667 shares at $0.72 ($2,647)
- 4 Open-market sale EVP, CFO & Treasurer sold 7,050 shares at $0.72 ($5,089)
- 4 Open-market sale EVP & Chief Commercial Officer sold 5,356 shares at $0.72 ($3,866)
- 4 Open-market sale President and CEO sold 3,608 shares at $0.93 ($3,355)
- 4 Open-market sale EVP, Chief Development Officer sold 2,883 shares at $1.06 ($3,056)
- 4 Open-market sale President and CEO sold 3,616 shares at $0.85 ($3,077)
- 4 Open-market sale Director sold 818,044 shares at an average $0.96 ($785,027)
- 4 Open-market sale EVP, CFO & Treasurer sold 652 shares at $0.99 ($645)
- 4 Open-market sale President and CEO sold 3,592 shares at $0.99 ($3,556)
- 4 Open-market sale Director sold 906,178 shares at an average $0.97 ($880,693)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 3,576 shares at $1.13 ($4,041)
- 4 Open-market sale EVP & Chief Medical Officer sold 6,789 shares at $1.17 ($7,943)
Page 5 of 31 · 601 filings